Endo Pharmaceuticals to Hold Conference Call and Webcast on Second Quarter 2008 Financial Results

* Reuters is not responsible for the content in this press release.

Tue Jul 22, 2008 9:00am EDT 

  CHADDS FORD, PA, Jul 22 (MARKET WIRE) -- 
Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) will announce its
second quarter financial results on July 31, and will hold a conference
call at 11:00 a.m. ET that day to discuss these results.

    David P. Holveck, President and Chief Executive Officer, Nancy J.
Wysenski, Chief Operating Officer, Charles A. Rowland, Jr., Chief
Financial Officer, Ivan Gergel, Executive Vice President, Research and
Development and Blaine Davis, Vice President, Investor Relations &
Communications, will host the call.

    Investors and other interested parties may call 888-713-4213 (domestic) or
617-213-4865 (international) and enter code 45330334. Please dial in 10
minutes prior to the scheduled start time.

    A replay of the call will be available from July 31 at 1:00 p.m. ET until
12:00 a.m. ET on August 7 by dialing 888-286-8010 (domestic) or
617-801-6888 (international), passcode 15128485.

    A simultaneous webcast of the call may be accessed by visiting
www.endo.com. In addition, a replay of the webcast will be available until
12:00 a.m. ET on August 7. The replay can be accessed by clicking on
"Events" in the Investor Relations section of the website.

    About Endo

    Endo Pharmaceuticals Holdings Inc. is a specialty pharmaceutical company
engaged in the research, development, sale and marketing of branded and
generic prescription pharmaceuticals used primarily to treat and manage
pain. More information, including this and past press releases of Endo
Pharmaceuticals Holdings Inc., is available at www.endo.com.

    



Copyright 2008, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.